Antimicrobial Susceptibility Testing Market Fueling Growth Of Infection Management

https://www.coherentmarketinsights.com/market-insight/antimicrobial-susceptibility-testing-market-2449
Antimicrobial Susceptibility Testing Market 



The global Antimicrobial Susceptibility Testing Market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview

Antimicrobial susceptibility testing determines which antibiotics can effectively treat bacterial or fungal infections. It is an important diagnostic tool that helps clinicians select the most appropriate antibiotic for treating an infection.

Market key trends

Rising number of diagnostic tests performed: Growing prevalence of infectious diseases, emergence of antimicrobial resistance, and need for effective infection management is increasing the demand for antimicrobial susceptibility testing globally. According to the World Health Organization (WHO), resistant bacteria and fungi cause above 700,000 deaths each year worldwide. As a result, the need for diagnostic testing to accurately detect resistant strains and guide treatment decisions is growing significantly.

Segment Analysis

The global antimicrobial susceptibility testing market is dominated by the susceptibility testing instruments/products segment. This segment holds the largest market share due to the increasing use of molecular diagnostic instruments for accurate and timely antimicrobial susceptibility testing results. Within this segment, automated instruments sub-segment dominates over the manual instruments owing to its benefits such as reduced turnaround time, increased throughput, and reproducible results.

Key Takeaways

The global Antimicrobial Susceptibility Testing Market Demand is expected to witness high growth, exhibiting CAGR of 6.4% over the forecast period, due to the increasing prevalence of infectious diseases and rising initiatives by governments and healthcare organizations to prevent AMR.

Regional analysis
North America dominates the global antimicrobial susceptibility testing market and is expected to continue its dominance over the forecast period. This is attributed to the growing incidence of infectious diseases, increasing funding and initiatives to prevent antimicrobial resistance in the region. Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to rising healthcare expenditure, an increasing number of hospitals in emerging countries, and growing awareness regarding AMR.

Key players
Key players operating in the antimicrobial susceptibility testing market are HiMedia Laboratories, Alifax S.r.l. Italy, Creative Diagnostics, Resistell AG, Danaher, Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc., Bruker, Nissui Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd.,Synbiosis, Mast Group Ltd., ELITechGroup, Flinn Scientific, CONDALAB, Accelerate Diagnostics, Inc. and Zhuhai DL Biotech Co., Ltd.

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries